Page last updated: 2024-10-22

aminoglutethimide and Blood Diseases

aminoglutethimide has been researched along with Blood Diseases in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Marked leukopenia and/or thrombocytopenia occurred in 12 of 1333 patients treated with aminoglutethimide (0."3.67Aminoglutethimide-induced hematologic toxicity: worldwide experience. ( Boucher, AE; Buzdar, AU; Harvey, HA; Henderson, IC; Lipton, A; Messeih, AA; Murray, R; Nagel, GA; Ragaz, J; Santen, RJ, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Messeih, AA1
Lipton, A1
Santen, RJ1
Harvey, HA1
Boucher, AE1
Murray, R1
Ragaz, J1
Buzdar, AU1
Nagel, GA1
Henderson, IC1

Other Studies

1 other study available for aminoglutethimide and Blood Diseases

ArticleYear
Aminoglutethimide-induced hematologic toxicity: worldwide experience.
    Cancer treatment reports, 1985, Volume: 69, Issue:9

    Topics: Aminoglutethimide; Blood Cell Count; Breast Neoplasms; Female; Global Health; Hematologic Diseases;

1985